Table 2.
Surgical methods and postoperative outcomes.
| RANSM with IBR (n = 12) | |
|---|---|
| Operated site | |
| Left | 5 (41.7) |
| Right | 7 (58.3) |
| Reconstruction | |
| Tissue expander insertion | 9 (75) |
| Direct-to-implant | 3 (25) |
| Gas insufflation | |
| No | 10 (83.3) |
| Yes | 2 (16.7) |
| SLNB (n = 10)* | |
| No | 0 (0) |
| Yes | 10 (100) |
| ALND (n = 10)* | |
| No | 9 (90) |
| Yes | 1 (10) |
| Length of hospitalization (days) | 11 (9–13) |
| Total operation time (min) | 351 (267–480) |
| Console time (min) | 51 (18–143) |
| Margin status | |
| Negative | 10 (83.3) |
| Positive | 2 (16.7) |
| Complication | |
| None | 9 (75) |
| Skin ischemia | 2 (16.7) |
| Nipple ischemia | 1 (8.3) |
Values are represented as median (minimum–maximum) or N (percentage).
*2 cases showed a benign presentation.
ALND: axillary lymph node dissection, IBR: immediate breast reconstruction, RANSM: robot-assisted nipple-sparing mastectomy, SLNB: sentinel lymph node biopsy.